Skip to main content

Notice: this Wiki will be going read only early in 2024 and edits will no longer be possible. Please see: https://gitlab.eclipse.org/eclipsefdn/helpdesk/-/wikis/Wiki-shutdown-plan for the plan.

Jump to: navigation, search

Difference between revisions of "M2T Meeting 2008-04-17"

(Set up meeting)
 
(Call Information)
Line 3: Line 3:
  
 
=== Call Information ===
 
=== Call Information ===
 +
{| border="1" cellpadding="5" cellspacing="0"
 +
|+ Call Information
 +
| Conference ID || 1556241
 +
|-
 +
| Local Dial-in number || 613-787-5018
 +
|-
 +
| Toll-free Dial-in number || 1 866-842-3549
 +
|-
 +
| International Toll-free Dial-in number || 800-4444-7070
 +
|-
 +
| Information || 1 866 224-5844
 +
|}
  
 +
* International Toll-free number notes
 +
** Dialing from a cellular network does not work!
 +
** If the conference ID is not recognized, try again. After the third failure, you will be transfered to an operator who will ask for the conference ID (1556241), sponsoring company (IBM) and meeting organizer (Paul Elder).
 +
** Pressing *0 may bring you directly to an operator.
  
 
==Agenda==
 
==Agenda==

Revision as of 11:00, 14 April 2008

Time

  • Thu, Apr 17 @ 1700 CET, 1100 EDT, 0800 PDT

Call Information

Call Information
Conference ID 1556241
Local Dial-in number 613-787-5018
Toll-free Dial-in number 1 866-842-3549
International Toll-free Dial-in number 800-4444-7070
Information 1 866 224-5844
  • International Toll-free number notes
    • Dialing from a cellular network does not work!
    • If the conference ID is not recognized, try again. After the third failure, you will be transfered to an operator who will ask for the conference ID (1556241), sponsoring company (IBM) and meeting organizer (Paul Elder).
    • Pressing *0 may bring you directly to an operator.

Agenda

  • TBD

Attendees

  • TBD

Minutes

  • TBD

Next meeting

  • Every third Thursday of the month. Reminders will be automatically sent to m2t-dev@eclipse.org
  • The next meeting Thursday, May 15

Copyright © Eclipse Foundation, Inc. All Rights Reserved.